Commons is our philosophy, which is part of our European history. We feel that our CRISPR-Cas based technology is of such importance that it should be easily accessible to the community. In both human and animal health this philosophy already paid off, since different partners from all the corners of Europe, are trained and using our CRISPR-Cas based inventions. Currently, we focus with our European partners on:
- Colorectal cancer (D)
- Leptospirossis (D)
